Steris Corp (STE) Stock Price, Quote & News

Company Profile

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the pro...

Industry: Medical Devices

Sector: Healthcare

Phone: 440 354 2600

Website: www.steris.com

Address:

5960 Heisley Road, Mentor, United States

BillionerOfKing Jun. 22 at 10:32 PM

$STE Current Stock Price: $200.37 Contracts to trade: $210.0 STE Jul 17 2026 Call Entry: $0.90 Exit: $1.22 ROI: 36% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

NVDAMillionaire Jun. 10 at 8:30 AM

$STE Really good write-up that perfectly summarizes STE's present situation. So if you want to bring your STE knowledge up to date or just discover STE, this is required reading. https://everyticker.com/quote/STE/analysis/steris-margin-expansion-meets-capital-allocation-excellence-in-infection-prevention-nyse-ste

0 · Reply

Parlandoconme Jun. 1 at 3:26 PM

$TOMZ will eclipse the dollar price today. $STE $ECL Twelve million annual will be in rear view mirror next year. Europe,Africa,Canada all moving to this new technology. BENE !

0 · Reply

d_risk Jun. 1 at 1:39 PM

$STE - STERIS plc (Ireland) - 10K - Updated Risk Factors STE flags higher exposure to shifting trade rules and USMCA’s 2026 review, new Medicaid and tax uncertainty from the 2025 OBBBA, potential double taxation and GloBE impacts given its Irish parent, expanding ESG and EU/US sustainability reporting burdens, EO-sterilization litigation and settlements, execution risk in smart manufacturing and AI adoption, and greater risk that acquisitions, investments, and realignment initiatives may not deliver expected returns. #HealthcareEquipment #TradePolicyRisk #TaxUncertainty #ESGReporting #AIAdoption 🟢 Added 🟠 Removed https://d-risk.ai/STE/10-K/2026-05-29

0 · Reply

Parlandoconme May. 29 at 11:14 AM

$TOMZ Spraying work areas set up to protect HC workers in Ebola zone. $STE $ECL Next thing you know,will be trading over a buck? Wonder if BSL3-4 in USA use Steramist? Buy.

0 · Reply

KopOut May. 27 at 1:55 PM

$STE position started

0 · Reply

Parlandoconme May. 26 at 5:51 PM

$TOMZ Insiders know more about the merger than outsiders. HEHEHE. $STE $ECL Only Steramist can do what it can do. Buy.Buy.Buy again.

0 · Reply

Parlandoconme May. 19 at 2:17 PM

$TOMZ Spray the Ebola mio amico. $STE EPA and CDC love Steramist. World Health Org needs to jump on this threat.

0 · Reply

MarketBeat May. 15 at 10:12 AM

https://marketbeat.com/a/8656093/ $STE STERIS Q4 Earnings Call Highlights

0 · Reply

Parlandoconme May. 15 at 9:36 AM

$TOMZ In Italia, Steramist viene adottato nei laboratori di biotecnologia. BASTA !!! $STE

0 · Reply

STERIS Proxy statement: Proxy filing

Jun 11, 2026, 8:00 AM EDT - 15 days ago

STERIS Proxy statement: Proxy filing

2026-05-13T11:31:52.000Z - 6 weeks ago

Steris price target lowered to $269 from $291 at KeyBanc

May 12, 2026, 9:00 AM EDT - 6 weeks ago

STERIS Earnings Call Transcript: Q4 2026

May 12, 2026, 9:00 AM EDT - 6 weeks ago

STERIS Earnings release: Q4 2026

May 12, 2026, 9:00 AM EDT - 6 weeks ago

STERIS Annual report: Q4 2026

May 12, 2026, 7:00 AM EDT - 6 weeks ago

STERIS Slides: Investor presentation

2026-05-11T23:52:15.000Z - 6 weeks ago

Steris reports Q4 adjusted EPS $2.83, consensus $2.85

2026-05-11T23:43:33.000Z - 6 weeks ago

Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08

May 11, 2026, 6:33 PM EDT - 6 weeks ago

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

May 11, 2026, 4:30 PM EDT - 6 weeks ago

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

May 7, 2026, 4:30 PM EDT - 7 weeks ago

STERIS Appoints Pierre Boulud to Board of Directors

May 5, 2026, 4:30 PM EDT - 7 weeks ago

STERIS Announces Dividend of $0.63 per share

Apr 21, 2026, 4:30 PM EDT - 2 months ago

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

Feb 5, 2026, 9:00 AM EST - 5 months ago

STERIS Earnings Call Transcript: Q3 2026

Feb 5, 2026, 9:00 AM EST - 5 months ago

STERIS Quarterly report: Q3 2026

Feb 5, 2026, 9:00 AM EST - 5 months ago

STERIS Earnings release: Q3 2026

2026-02-04T21:40:54.000Z - 5 months ago

Steris sees FY26 adjusted EPS $10.15-$10.30, consensus $10.21

2026-02-04T21:35:27.000Z - 5 months ago

Steris reports Q3 adjusted EPS $2.53, consensus $2.53

Feb 4, 2026, 4:30 PM EST - 5 months ago

STERIS Announces Financial Results for Fiscal 2026 Third Quarter

Jan 21, 2026, 4:30 PM EST - 5 months ago

STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026

Jan 20, 2026, 4:30 PM EST - 5 months ago

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

MTD

Nov 6, 2025, 9:00 AM EST - 8 months ago

STERIS Earnings Call Transcript: Q2 2026

Nov 6, 2025, 9:00 AM EST - 8 months ago

STERIS Quarterly report: Q2 2026

Nov 6, 2025, 9:00 AM EST - 8 months ago

STERIS Earnings release: Q2 2026

2025-11-05T23:10:53.000Z - 8 months ago

Steris raises FY26 adjusted EPS view to $10.15-$10.30 from $9.90-$10.15

2025-11-05T23:05:17.000Z - 8 months ago

Steris reports Q2 adjusted EPS $2.47, consensus $2.35

Nov 5, 2025, 4:30 PM EST - 8 months ago

STERIS Announces Financial Results for Fiscal 2026 Second Quarter

Oct 21, 2025, 4:30 PM EDT - 8 months ago

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025

2025-09-29T20:50:19.000Z - 9 months ago

Steris management to meet with Piper Sandler

2025-08-19T19:25:17.000Z - 11 months ago

Steris management to meet virtually with KeyBanc

Aug 7, 2025, 9:00 AM EDT - 11 months ago

STERIS Earnings Call Transcript: Q1 2026

Aug 7, 2025, 9:00 AM EDT - 11 months ago

STERIS Quarterly report: Q1 2026

Aug 7, 2025, 9:00 AM EDT - 11 months ago

STERIS Earnings release: Q1 2026

2025-08-06T20:47:59.000Z - 11 months ago

Steris reports Q1 adjusted EPS $2.34, consensus $2.26

2025-08-06T20:46:50.000Z - 11 months ago

Steris affirms fiscal 2026 adjusted EPS outlook $9.90-$10.15, consensus $10.04

2025-08-06T20:45:54.000Z - 11 months ago

Steris CFO Michael Tokich stepping down, Karen Burton to succeed

Aug 6, 2025, 4:31 PM EDT - 11 months ago

STERIS Announces Chief Financial Officer Transition

Aug 6, 2025, 4:30 PM EDT - 11 months ago

STERIS Announces Financial Results for Fiscal 2026 First Quarter

2025-07-30T21:10:30.000Z - 11 months ago

Steris increases quarterly dividend to 63c per share

Jul 30, 2025, 4:30 PM EDT - 11 months ago

STERIS Raises Dividend to $0.63 per share

Jul 22, 2025, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

2025-07-22T12:21:43.000Z - 1 year ago

Steris price target raised to $288 from $277 at KeyBanc

2025-07-15T10:10:30.000Z - 1 year ago

Steris upgraded to Overweight from Equal Weight at Morgan Stanley

Jul 3, 2025, 8:00 AM EDT - 1 year ago

STERIS Proxy statement: Proxy Filing

Jun 12, 2025, 8:00 AM EDT - 1 year ago

STERIS Proxy statement: Proxy Filing

Jun 12, 2025, 8:00 AM EDT - 1 year ago

STERIS Proxy statement: Proxy Filing

May 27, 2025, 7:00 AM EDT - 1 year ago

STERIS Slides: Investor Presentation

May 20, 2025, 7:57 AM EDT - 1 year ago

U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More

May 15, 2025, 12:39 PM EDT - 1 year ago

Why This Medical Equipment Stock Is Today's S&P 500 Winner

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings Call Transcript: Q4 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Annual report: Q4 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings release: Q4 2025

May 14, 2025, 5:26 PM EDT - 1 year ago

Steris forecasts annual profit above estimates on strong medical equipment sales

May 14, 2025, 5:06 PM EDT - 1 year ago

Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

May 14, 2025, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

May 7, 2025, 4:30 PM EDT - 1 year ago

STERIS Declares Dividend of $0.57 per share

Apr 22, 2025, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

Feb 12, 2025, 7:00 AM EST - 1 year ago

STERIS Slides: Investor Presentation

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Earnings Call Transcript: Q3 2025

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Quarterly report: Q3 2025

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Earnings release: Q3 2025

Feb 5, 2025, 6:43 PM EST - 1 year ago

Steris lowers annual profit forecast due to a stronger dollar

Feb 5, 2025, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

Jan 22, 2025, 4:30 PM EST - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

Jan 21, 2025, 6:30 AM EST - 1 year ago

STERIS Announces Outcome of Ethylene Oxide Trial

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Earnings Call Transcript: Q2 2025

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Quarterly report: Q2 2025

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Earnings release: Q2 2025

Nov 6, 2024, 5:44 PM EST - 1 year ago

Steris beats quarterly estimates on continued demand for medical procedures

Nov 6, 2024, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

Oct 23, 2024, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024

Oct 9, 2024, 3:39 PM EDT - 1 year ago

STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement

Sep 4, 2024, 1:50 PM EDT - 1 year ago

STERIS Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 26, 2024, 4:30 PM EDT - 1 year ago

STERIS to Present at the Morgan Stanley Healthcare Conference

Aug 7, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings Call Transcript: Q1 2025

Aug 7, 2024, 9:00 AM EDT - 2 years ago

STERIS Quarterly report: Q1 2025

Aug 7, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings release: Q1 2025

Aug 6, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2025 First Quarter

Jul 31, 2024, 4:30 PM EDT - 2 years ago

STERIS Raises Dividend to $0.57 per share

Jul 23, 2024, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024

Jun 12, 2024, 8:00 AM EDT - 2 years ago

STERIS Proxy statement: Proxy Filing

Jun 12, 2024, 8:00 AM EDT - 2 years ago

STERIS Proxy statement: Proxy Filing

Jun 3, 2024, 7:00 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings Call Transcript: Q4 2024

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Annual report: Q4 2024

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings release: Q4 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year

May 1, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Dividend of $0.52 per share

Apr 24, 2024, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024

Apr 11, 2024, 7:30 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP

Apr 11, 2024, 6:58 AM EDT - 2 years ago

STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Earnings Call Transcript: Q3 2024

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Quarterly report: Q3 2024

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Earnings release: Q3 2024

Feb 7, 2024, 6:35 PM EST - 2 years ago

Steris beats third-quarter estimates on strong medical procedure demand

Feb 7, 2024, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Third Quarter

Jan 23, 2024, 4:30 PM EST - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024

Nov 8, 2023, 9:00 AM EST - 2 years ago

STERIS Earnings Call Transcript: Q2 2024

Nov 8, 2023, 9:00 AM EST - 2 years ago

STERIS Quarterly report: Q2 2024

Nov 8, 2023, 9:00 AM EST - 2 years ago

STERIS Earnings release: Q2 2024

Nov 7, 2023, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Second Quarter

Oct 24, 2023, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023

Sep 13, 2023, 8:10 AM EDT - 3 years ago

STERIS Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

Aug 2, 2023, 9:00 AM EDT - 3 years ago

STERIS Earnings Call Transcript: Q1 2024

Aug 2, 2023, 9:00 AM EDT - 3 years ago

STERIS Quarterly report: Q1 2024

Aug 2, 2023, 9:00 AM EDT - 3 years ago

STERIS Earnings release: Q1 2024

Aug 1, 2023, 5:39 PM EDT - 3 years ago

Medical device maker Steris lifts 2024 results view, records quarterly beat

Aug 1, 2023, 4:30 PM EDT - 3 years ago

STERIS Announces Financial Results for Fiscal 2024 First Quarter

Jul 26, 2023, 4:30 PM EDT - 3 years ago

STERIS Raises Dividend to $0.52 per share

Jul 19, 2023, 4:30 PM EDT - 3 years ago

STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023

Jun 20, 2023, 8:18 AM EDT - 3 years ago

Steris paying $540 mln for BD surgical instrument unit

BDX

BillionerOfKing Jun. 22 at 10:32 PM

0 · Reply

NVDAMillionaire Jun. 10 at 8:30 AM

0 · Reply

Parlandoconme Jun. 1 at 3:26 PM

$TOMZ will eclipse the dollar price today. $STE $ECL Twelve million annual will be in rear view mirror next year. Europe,Africa,Canada all moving to this new technology. BENE !

0 · Reply

d_risk Jun. 1 at 1:39 PM

0 · Reply

Parlandoconme May. 29 at 11:14 AM

$TOMZ Spraying work areas set up to protect HC workers in Ebola zone. $STE $ECL Next thing you know,will be trading over a buck? Wonder if BSL3-4 in USA use Steramist? Buy.

0 · Reply

KopOut May. 27 at 1:55 PM

$STE position started

0 · Reply

Parlandoconme May. 26 at 5:51 PM

$TOMZ Insiders know more about the merger than outsiders. HEHEHE. $STE $ECL Only Steramist can do what it can do. Buy.Buy.Buy again.

0 · Reply

Parlandoconme May. 19 at 2:17 PM

$TOMZ Spray the Ebola mio amico. $STE EPA and CDC love Steramist. World Health Org needs to jump on this threat.

0 · Reply

MarketBeat May. 15 at 10:12 AM

https://marketbeat.com/a/8656093/ $STE STERIS Q4 Earnings Call Highlights

0 · Reply

Parlandoconme May. 15 at 9:36 AM

$TOMZ In Italia, Steramist viene adottato nei laboratori di biotecnologia. BASTA !!! $STE

0 · Reply

EarningsInsider May. 12 at 2:01 PM

https://www.marketbeat.com/earnings/reports/2026-5-11-steris-plc-stock/ $STE STERIS Earnings Transcript

0 · Reply

StocktwitsEarnings May. 11 at 8:45 PM

$STE Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $2.25 up 52.03% YoY • Reported revenue of $1.59B up 7.28% YoY • STERIS anticipates fiscal 2027 as reported revenue to increase 7-8% and adjusted diluted EPS to range from $11.10 to $11.30, an increase of 9-11%. Free cash flow is expected to be approximately $850 million for Steris Plc.

0 · Reply

DonCorleone77 May. 11 at 8:43 PM

$STE Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08 Sees FY27 revenue growth 7%-8% from $5.9B, consensus $6.31B. Sees FY27 CapEx $375M.

0 · Reply

DonCorleone77 May. 11 at 8:40 PM

$STE Steris reports Q4 adjusted EPS $2.83, consensus $2.85 Reports Q4 revenue $1.6B, consensus $1.6B. "FY26 was another record year," said CEO Dan Carestio. "Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associates who continue to put our Customers first. As we look ahead, we are excited for what is to come as we capitalize on our unique ability to help our Customers enable procedural growth, deliver quality outcomes and drive compliance with standardization and optimization."

0 · Reply

Huck18 May. 11 at 8:36 PM

$STE A miss and a Rise, vs. last Q the opposite ... Funny but Expected at this low price

0 · Reply

1986iamwallstreet May. 11 at 8:35 PM

$STE Steris Q4 Adj. EPS $2.83 Misses $2.85 Estimate, Sales $1.588B Miss $1.595B Estimate Double miss

0 · Reply

BillionerOfKing May. 11 at 3:59 PM

$STE Current Stock Price: $202.84 Contracts to trade: $210.0 STE May 15 2026 Call Entry: $2.50 Exit: $3.33 ROI: 33% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Parlandoconme May. 11 at 10:07 AM

$TOMZ L'Europa è pronta a decontaminarsi con Steramist. Most systems have become obsolete.This will be worth millions soon.Great patents IMO. $STE The Global Bio-Decontamination Market Size is anticipated to reach USD 517.7 Million by 2035.

0 · Reply

Parlandoconme May. 10 at 10:59 AM

$TOMZ This company has serious upside based on the earnings conference call. Decon chambers,robo rides,bio lab decon,food security. Unlimited. $STE

0 · Reply

Parlandoconme May. 7 at 10:53 AM

$TOMZ Live chat today at 1pm with Steramist and Carbonium CEOs. $13BILLION industry about to get steramisted! $TSLA $STE

0 · Reply

BillionerOfKing May. 6 at 10:21 PM

$STE Current Stock Price: $214.52 Contracts to trade: $220.0 STE May 15 2026 Call Entry: $2.90 Exit: $4.75 ROI: 64% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 6 at 6:54 PM

$STE Price: $214.29 (+0.62%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.76% RSI: 42.9 | Momentum: Moderate Volume: -60.2% vs avg Volatility: 1.49% Support: $209.61 | Resistance: $227.87 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

Market Cap	20.19B
Revenue (ttm)	5.94B
Net Income (ttm)	782.30M
EPS (ttm)	N/A
PE Ratio	19.98
Forward PE	18.18
Profit Margin	13.18%
Debt to Equity Ratio	0.27

Volume	1,232,345
Avg Vol	826,720
Day's Range	N/A - N/A
Shares Out	97.46M
Stochastic %K	76%
Beta	0.93
Analysts	Strong Sell
Price Target	$259.00